Literature DB >> 11291737

Triage for Leiurus quinquestriatus scorpion envenomation in children--is routine ICU hospitalization necessary?

R Ben-Abraham1, G Eschel, E Winkler, A A Weinbroum, Z Barzilay, G Paret.   

Abstract

(1) Leiurus quinquestriatus scorpion (LQS) envenomation is a common public health problem with a similar clinical presentation in the Middle East and worldwide: localized reactions occur in up to 97% of the victims. (2) LQS envenomation in children is potentially fatal since the severity of symptoms is weight-dependent. (3) A common policy is to hospitalize all children stung by the LQS-regardless of clinical severity-in the pediatric intensive care unit (PICU). (4) Seventeen of 18 children treated at two Israeli medical centers during an 8-year period developed mild to moderate clinical manifestations (antivenin was given in the one severe case; all children survived): all 18 had been transferred to an ICU for surveillance. Since patient care in PICUs is far more costly and manpower-intense than in general emergency rooms, we propose that a protocol of 6 h of surveillance in the emergency department is adequate and safe for most children who had been stung by LQS. Only children who develop systemic manifestations should be hospitalized and transferred to the intensive care unit. (5) Further prospective studies should be conducted to define specific subgroups that may benefit from these recommendations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11291737     DOI: 10.1191/096032700666836486

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice.

Authors:  Mitsuteru Akahoshi; Chang Ho Song; Adrian M Piliponsky; Martin Metz; Andrew Guzzetta; Magnus Abrink; Susan M Schlenner; Thorsten B Feyerabend; Hans-Reimer Rodewald; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

2.  Isolation and characterization of CvIV4: a pain inducing α-scorpion toxin.

Authors:  Ashlee H Rowe; Yucheng Xiao; Joseph Scales; Klaus D Linse; Matthew P Rowe; Theodore R Cummins; Harold H Zakon
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.